- Investing Ideas
- /
- Global Potentially Undervalued Companies
Global Potentially Undervalued Companies
UPDATED May 22, 2024
Companies with a Value score of at least 3, ordered by Value score
33,124 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
6929 | HK$3.83 | -24.5% | n/a | HK$3.2b | HK$9.06 | PE10.6x | E7.6% | n/a | Healthcare | ||
506 | HK$2.84 | -0.4% | 15.0% | HK$7.8b | HK$3.90 | PE9.4x | E5.9% | 4.5% | Food, Beverage & Tobacco | ||
SIA | €136.72 | 1.3% | 32.2% | €106.4b | €180.58 | PE11.8x | E1.2% | 3.2% | Capital Goods | ||
CRR | €17.28 | 1.5% | 6.3% | €12.6b | €21.14 | PE12.2x | E6.7% | 3.0% | Consumer Retailing | ||
NTR | US$0.93 | 0.5% | 11.6% | US$209.9m | US$1.13 | PS8.2x | E67.3% | n/a | Pharmaceuticals & Biotech | ||
HAM | CA$6.75 | 2.3% | -32.4% | CA$102.2m | CA$9.42 | PE2.2x | E-25.6% | n/a | Energy | ||
DTG | €39.33 | -4.3% | 40.0% | €31.6b | €52.74 | PE8.2x | E5.4% | 4.8% | Capital Goods | ||
CWB | CA$27.01 | -0.7% | 10.7% | CA$2.6b | CA$34.10 | PB0.7x | E11.2% | 5.0% | Banks | ||
AFN | CA$46.81 | -5.7% | -10.8% | CA$904.0m | CA$79.11 | PE16.4x | E30.6% | 1.3% | Capital Goods | ||
FINV | US$4.77 | -7.6% | 19.3% | US$1.2b | US$6.27 | PE4.1x | E14.3% | 4.3% | Diversified Financials | ||
0J9O | €7.34 | -7.1% | -65.4% | €63.0m | €13.29 | PB0.6x | E123.4% | n/a | Semiconductors | ||
GLO | €20.30 | 0% | -3.8% | €593.8m | €24.89 | PE9.9x | E8.6% | 3.4% | Commercial Services | ||
S49 | US$25.60 | -3.8% | -18.5% | US$1.5b | US$37.35 | PS2.6x | E60.0% | n/a | Pharmaceuticals & Biotech | ||
9NI | JP¥5.75 | -10.9% | -27.7% | JP¥113.1b | JP¥7.18 | PE5x | E-6.4% | 1.0% | Materials | ||
AMPH | US$43.46 | 2.4% | -1.4% | US$2.0b | US$62.60 | PE13.7x | E16.8% | n/a | Pharmaceuticals & Biotech | ||
ECVT | US$9.45 | -1.6% | -11.1% | US$1.1b | US$13.86 | PE15x | E29.1% | n/a | Materials | ||
TPEIR | €3.79 | -2.4% | 37.9% | €4.7b | €5.06 | PB0.6x | E4.1% | n/a | Banks | ||
TCL.A | CA$13.37 | -1.8% | -8.7% | CA$1.2b | CA$19.08 | PE11.7x | E12.2% | 6.7% | Materials | ||
CBE | €39.30 | 0.6% | 5.5% | €938.6m | €50.75 | PE11.5x | E12.4% | 3.2% | Capital Goods | ||
VRLA | €36.68 | 1.1% | 1.0% | €4.3b | €45.38 | PE9.1x | E1.6% | 5.9% | Materials | ||
C520 | US$46.00 | -4.2% | -8.9% | US$2.8b | US$66.78 | PS1.5x | E106.2% | n/a | Healthcare | ||
BON | €7.76 | -2.1% | -32.6% | €249.3m | €10.78 | PB0.3x | E73.0% | 3.2% | Food, Beverage & Tobacco | ||
AGJ | US$98.74 | -8.1% | -8.2% | US$8.1b | US$121.58 | PE7.3x | E-5.0% | 3.4% | Capital Goods | ||
FUP | JP¥8.40 | -4.5% | 5.0% | JP¥35.1b | JP¥11.98 | PE5.9x | E-10.0% | 2.8% | Pharmaceuticals & Biotech |